TrialSignal
Clinical trial intelligence report
Conversational Engagement as a Means to Delay Alzheimer's Disease Onset
Source-linked diligence brief with registry provenance, taxonomy normalization and premium analytical context.
Generated
Jul 28, 2026
Report code
NCT01571427-Jul 28, 2026
NCT ID
NCT01571427
Status
COMPLETED
Phase
Completed (Early Phase 1)
Sponsor
Oregon Health and Science University
Executive brief
Investment-Ready Snapshot
The study conducted by Oregon Health and Science University explored the potential of conversation-based cognitive stimulation to delay the onset of Alzheimer's Disease in non-demented elderly participants. Given the increasing prevalence of Alzheimer's and the aging population, this intervention could represent a cost-effective, scalable approach to cognitive health management. The results may position the sponsor favorably in the behavioral intervention market, which is gaining traction as an adjunct to pharmacological treatments. The competitive landscape includes other cognitive enhancement strategies, but this study's unique focus on social engagement could differentiate it. Diligence should focus on the scalability of the intervention and potential partnerships with healthcare providers and senior living communities.
Source & freshness
Provenance
https://clinicaltrials.gov/study/NCT01571427
Indication
Mild Cognitive Impairment
Modality
medical device
Target
Conversational engagement as a behavioral intervention to enhance cognitive function in elderly individuals at risk for Alzheimer's Disease.
Intervention
Active social engagement group, Control group
Source record
Protocol Description
Detailed source ingestion pending.
Source record
Outcome Measures
Detailed source ingestion pending.
Source record
Eligibility
Detailed source ingestion pending.
AI analysis
Known Results And Readout Context
Detailed source ingestion pending.
IP intelligence
Patent And IP Landscape
Detailed source ingestion pending.
Source record
Contacts
Detailed source ingestion pending.